The India Cements (INDIACEM) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
2 Feb, 2026Executive summary
Robust demand driven by government infrastructure projects and marquee investments, supporting strong cement consumption outlook across all regions.
Domestic sales volume reached 2.59 MnT in Q3 FY26, marking a 25% year-over-year increase.
Capacity utilization improved to 69%, up 11% year-over-year.
Integration of recent acquisitions is ahead of plan, with significant brand conversion and cost improvement programs underway.
Standalone and consolidated unaudited financial results for the quarter and nine months ended 31 December 2025 were approved and reviewed by the Board and Audit Committee.
Financial highlights
Standalone revenue from operations for the quarter was ₹1,114.13 crore, up from ₹902.19 crore year-over-year; consolidated revenue was ₹1,114.26 crore.
Net sales for Q3 FY26 were ₹1,103 Crores, up from ₹874 Crores in Q3 FY25.
EBITDA for Q3 FY26 was ₹105 Crores (standalone), compared to a loss of ₹178 Crores in Q3 FY25.
Standalone net loss for the quarter was ₹5.72 crore, compared to a net loss of ₹409.38 crore in the same quarter last year; consolidated net loss was ₹2.67 crore.
PAT before exceptional items stood at ₹6 Crores for the quarter.
Outlook and guidance
Expectation to operate at over 90% of installed capacity in the January-March quarter, indicating strong demand.
Capex plan of ₹2,000 Crores over the next two years focused on growth and efficiency improvements.
Plans to scale up green power (RE + WHRS) from 5% to 80% by FY29.
Guidance for 7-8% annual demand growth remains intact for the next 4-5 years.
The company continues to monitor regulatory changes, including new Labour Codes, and will review estimates as further clarifications are issued.
Latest events from The India Cements
- Sales and EBITDA improved as expansion, brand transition, and restructuring progressed.INDIACEM
Q2 25/263 Feb 2026 - Sales volume up to 11.6% YoY, EBITDA/ton improved, losses narrowed, double-digit growth targeted.INDIACEM
Q1 25/266 Jan 2026 - Profitability returned in Q1 FY25 on an exceptional gain, with major stake sale to UltraTech Cement.INDIACEM
Q1 24/251 Sep 2025 - Losses widened on lower revenue, with major asset sales and a pending UltraTech acquisition.INDIACEM
Q2 24/251 Sep 2025 - Q3 FY25 saw lower revenue, major losses, UltraTech's takeover, and large asset revaluation gains.INDIACEM
Q3 24/251 Sep 2025 - FY25 saw deeper losses, lower revenue, and major legal disputes, with auditors' unmodified opinions.INDIACEM
Q4 24/251 Sep 2025